Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Barriers to collecting patient race, ethnicity, and primary language data in physician practices: an exploratory study.
Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma.
Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma. Clin Cancer Res. 2016 Nov 15; 22(22):5461-5471.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antineoplastic Agents
B7-H1 Antigen
Carcinoma, Renal Cell
Chemokine CXCL10
Chemokine CXCL9
Everolimus
Female
Humans
Immunologic Factors
Interferon-gamma
Kidney Neoplasms
Lymphocytes
Male
Middle Aged
Prospective Studies
Tumor Microenvironment
Up-Regulation
authors with profiles
Walter M. Stadler